AI channel feed – Endpoints News

AI channel feed

Boehringer and Lonza question the future of FDA's regulation of AI in manufacturing

3 years ago

Durham startup raises Series A to tackle undruggable proteins, including cancer baddie Myc, with generative AI

3 years ago

MD Anderson, Flagship startup partner to design and test cancer drugs made with generative AI

3 years ago

Moderna, IBM turn to quantum computing in hunt for new mRNA medicines

3 years ago

AI tools don't equal guaranteed drug success as BenevolentAI flops dermatitis test

3 years ago

ChatGPT with pharma data debuts for medical meetings, beginning with AACR

3 years ago

Syneos Health inks deal with Microsoft to use AI technology

3 years ago

Bristol Myers passes on two Exscientia oncology candidates, but biotech to move them into clinic next year

3 years ago

Tempus founders build a drug discovery startup, Pathos AI, with $40M in sight

3 years ago

FDA set to open comments on AI use in pharma manufacturing

3 years ago

Merck-Novartis revolving door spins again as AI leader Iya Khalil switches pharmas

3 years ago

Alto Neuroscience bags $25M for four Phase II drugs

3 years ago

Profluent debuts to design proteins with machine learning in bid to move past 'AI sprinkled on top'

3 years ago

Neuralink employees cite layoffs at Elon Musk’s brain-computer interface startup

3 years ago

Former DeepMind intern launches Atomic AI to 'parse' RNA structure for new small molecules

3 years ago

AbbVie signs mRNA pact with Anima Biotech for $42M upfront

3 years ago

BioNTech buys out AI partner InstaDeep for $440M in bid to become ‘technology company’

3 years ago

'As the market has turned': Enveda secures $68M to move revised pipeline into the clinic in 2023

3 years ago

Simulations for experiments: Bayer-backed startup lands $20M to test out its tech

3 years ago

European protein software startup Cradle launches with backing from Lyft, Twist CEOs

3 years ago

In latest AI tie-up, Sanofi partners with Insilico for six new targets

3 years ago

Two former Stanford researchers nab a $41M launch round to learn the secrets of the ‘secretome’

3 years ago

Exscientia wants to bring its AI/ML approach into the world of biologics. It's starting with antibodies

3 years ago

Recursion discreetly culls a rare disease program to focus on cancer, pulls in $150M private placement

3 years ago

First page Previous page 5 6 789 10 11 Next page Last page